OrbiMed’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

OrbiMed’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-170,000	Closed	-$5.67M	–	142
2024 Q3	$5.67M	Buy	+170,000	New	+$5.85M	0.1%	96
2022 Q4	–	Sell	-113,500	Closed	-$422	–	138
2022 Q3	$422	Hold	113,500	–	–	0.01%	131
2022 Q2	$351	Hold	113,500	–	–	0.01%	142
2022 Q1	$606K	Hold	113,500	–	–	0.01%	139
2021 Q4	$554K	Hold	113,500	–	–	0.01%	156
2021 Q3	$1M	Hold	113,500	–	–	0.01%	166
2021 Q2	$1.03M	Sell	113,500 -186,500	-62%	-$1.86M	0.01%	157
2021 Q1	$4.91M	Buy	+300,000	New	+$4.9M	0.05%	144

OrbiMed's LBPH Position: Q4 2024 in Review

OrbiMed sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 170,000 shares — an estimated $5.67M sold.

OrbiMed first reported a position in LBPH in Q1 2021 and held it in 8 quarters. The position peaked at $5.67M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

OrbiMed reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
OrbiMed sold 170,000 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $5.67M.
OrbiMed first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
OrbiMed's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $5.67M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on OrbiMed's 13F filing for Q4 2024, filed 14 Feb 2025.